Publications by authors named "S Mulligan"

Claim this Profile
R
Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia.
Stephen P Mulligan, Philip A Thompson, Joel Wight, Mary Ann Anderson, Sasanka M Handunnetti

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status update: environmental sustainability in the dental profession.
Nicolas Martin, Jonathan Dixon, Steven Mulligan

Br Dent J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Mary Ann Anderson, Farrukh T Awan, Leanne Berkahn, Kyle Crassini, Hui-Peng Lee, Stephen P Mulligan

Intern Med J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and Myeloma.
Elizabeth Hughes, Sue Latham, Bryone Kuss, Scott Grist, Rachel Hall, Stephen Mulligan

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and CLL in Sweden: lessons learned?
Stephen P Mulligan

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis